Literature DB >> 10857848

Suppression of T cell function: a potential role for transcriptional repressor ICER.

J Bodor1, J Bodorova, R E Gress.   

Abstract

In this article, we review the inducible cAMP early repressor (ICER) and its possible critical involvement in modulation of T cell responsiveness by its capacity to transcriptionally attenuate interleukin-2 (IL-2) gene expression. It seems clear that the failure to produce the IL-2 is an important determinant of anergy induction. It is important that the CD28-responsive element (CD28RE), a composite DNA binding element consisting of NFAT and cyclic AMP-responsive (CRE)-like motifs in position of -160 of IL-2 promoter has the high affinity for ICER binding as well as NFAT/ICER complex formation. Moreover, CD28RE with adjacent DNA sequences was also shown to be essential for conferring anergy in T lymphocytes. Because ICER does not possess a transactivation domain required for the recruitment of CBP/p300, the binding of ICER to CD28RE and/or composite motifs containing CRE-like DNA motifs may lead to uncoupling of CBP/p300 thus extinguishing IL-2 expression as well as expression of numerous other cytokines and chemokines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10857848     DOI: 10.1002/jlb.67.6.774

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  19 in total

Review 1.  Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies.

Authors:  Adam Lerner; Paul M Epstein
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

Review 2.  Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target.

Authors:  Dorothy K Sojka; Yu-Hui Huang; Deborah J Fowell
Journal:  Immunology       Date:  2008-03-14       Impact factor: 7.397

3.  Modulation of NFAT-dependent gene expression by the RhoA signaling pathway in T cells.

Authors:  Whitney S Helms; Jerry L Jeffrey; Derek A Holmes; Michael B Townsend; Neil A Clipstone; Lishan Su
Journal:  J Leukoc Biol       Date:  2007-05-14       Impact factor: 4.962

4.  Differential effect of traumatic brain injury on the nuclear factor of activated T Cells C3 and C4 isoforms in the rat hippocampus.

Authors:  Samuel S Shin; Hong Q Yan; Xiecheng Ma; Youming Li; C Edward Dixon
Journal:  Brain Res       Date:  2013-12-31       Impact factor: 3.252

Review 5.  Protein kinase CK2, an important regulator of the inflammatory response?

Authors:  Nishi N Singh; Dipak P Ramji
Journal:  J Mol Med (Berl)       Date:  2008-04-25       Impact factor: 4.599

6.  Constitutive Expression of Inducible Cyclic Adenosine Monophosphate Early Repressor (ICER) in Cycling Quiescent Hematopoietic Cells: Implications for Aging Hematopoietic Stem Cells.

Authors:  Steven J Greco; Ghassan Yehia; Julius A Potian; Carlos A Molina; Pranela Rameshwar
Journal:  Stem Cell Rev Rep       Date:  2017-02       Impact factor: 5.739

7.  Interferon regulatory factor 2 binding protein 2 is a new NFAT1 partner and represses its transcriptional activity.

Authors:  Flávia R G Carneiro; Renata Ramalho-Oliveira; Giuliana P Mognol; João P B Viola
Journal:  Mol Cell Biol       Date:  2011-05-16       Impact factor: 4.272

8.  Regulation of cytotoxic T lymphocyte antigen 4 by cyclic AMP.

Authors:  Jinghong Li; Ko-Wei Lin; Fiona Murray; Takeshi Nakajima; Yandong Zhao; David L Perkins; Patricia W Finn
Journal:  Am J Respir Cell Mol Biol       Date:  2012-09-28       Impact factor: 6.914

Review 9.  cAMP responsive element modulator: a critical regulator of cytokine production.

Authors:  Thomas Rauen; Christian M Hedrich; Klaus Tenbrock; George C Tsokos
Journal:  Trends Mol Med       Date:  2013-03-13       Impact factor: 11.951

10.  PDE8 regulates rapid Teff cell adhesion and proliferation independent of ICER.

Authors:  Amanda G Vang; Shlomo Z Ben-Sasson; Hongli Dong; Barbara Kream; Michael P DeNinno; Michelle M Claffey; William Housley; Robert B Clark; Paul M Epstein; Stefan Brocke
Journal:  PLoS One       Date:  2010-08-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.